In this study it is illustrated that recombinant human interferon-gamma (IFN-gamma) acts as a B cell growth factor (BCGF) in the anti-IgM antibody co-stimulatory assay. A monoclonal antibody that specifically inhibits the biological activities of IFN-gamma blocks its BCGF activity supporting the specificity of the IFN-gamma effect. Various IFN-gamma obtained from different sources displayed the same BCGF activity. Nonactivated B lymphocytes do not proliferate in response to IFN-gamma. IFN-gamma acts directly on B cells because highly purified B cells obtained after standard purification procedures coupled to cell sorting could still proliferate in response to IFN-gamma. Blood B lymphocytes were found to be more sensitive to the BCGF activity of IFN-gamma than B cells obtained from spleens or tonsils. The IFN-gamma-induced proliferation of B cells was short lasting when compared with that of recombinant IL 2 or BCGF containing T cell clone supernatants. B cells preactivated with either Staphylococcus aureus strain Cowan I (SAC) or optimal concentrations of anti-IgM antibodies coupled to beads did not proliferate in response to IFN-gamma, whereas they proliferated in response to IL 2 or T cell clone supernatants. IFN-gamma did not stimulate nor inhibit the proliferative response of human B lymphocytes stimulated with optimal concentrations of anti-IgM antibodies or SAC. Additionally none of the different IFN-gamma tested had B cell differentiation factor activity in the standard SAC assay. These results indicate that IFN-gamma sensitizes B cells to suboptimal mitogenic concentrations of anti-IgM antibody.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
[Multifocal motor neuropathy. Report of three cases at a reference hospital in Mexico].
Rev Med Inst Mex Seguro Soc
March 2024
Instituto Mexicano del Seguro Social. Centro Médico Nacional Siglo XXI, Hospital de Especialidades "Dr. Bernardo Sepúlveda", Servicio de Neurofisiología. Ciudad de México, México.
Background: Motor multifocal neuropathy is an immunemediated neuropathy characterized by progressive and asymmetric weakness of the distal extremities, without sensory symptoms, and an important feature of conduction blocks. The objective of this study is to comprehensively describe the nosological and pathogenic implications of this neurodegenerative disorder, given the unclear diagnosis of MMN and the significant challenges it poses.
Clinical Cases: We present three clinical cases with a chronic clinical presentation, in which neuroconduction studies were performed, revealing the presence of anti-IgM GM1 antibodies, consistent with the diagnosis of motor multifocal neuropathy.
Electric Field Cycling of Physisorbed Antibodies Reduces Biolayer Polarization Dispersion.
Adv Sci (Weinh)
November 2024
Dipartimento di Chimica and Centre for Colloid and Surface Science, Università degli Studi di Bari Aldo Moro, Bari, 20125, Italy.
The electric dipoles of proteins in a biolayer determine their dielectric properties through the polarization density P. Hence, its reproducibility is crucial for applications, particularly in bioelectronics. Biolayers encompassing capturing antibodies covalently bound at a biosensing interface are generally preferred for their assumed higher stability.
View Article and Find Full Text PDFAnalysis of B cell proliferation in response to in vitro stimulation in patients with CVID.
Allergol Immunopathol (Madr)
September 2024
Laboratorio en Inmunodeficiencias, Instituto Nacional de Pediatría SSA, Ciudad de México, México;
Article Synopsis
- Common variable immunodeficiency (CVID) is a disorder marked by issues in B cell functioning and antibody production, with various responses depending on whether T cells are involved.
- A study comparing 23 CVID patients with 14 healthy donors analyzed B and T cell activity and proliferation under different stimuli, finding differing responses based on the presence of memory B cells.
- Results indicated that patients with lower memory B cells had increased follicular T cells and poor proliferation to certain stimuli, highlighting the need for more research to uncover the underlying mechanisms and potential genetic links to CVID.
Parvovirus B19 and Parvovirus 4 infections among healthy blood donors; A prevalence report from Iran.
IDCases
August 2024
Research Center for Molecular Medicine, Hamadan University of Medical Sciences, Hamadan, Islamic Republic of Iran.
Background: Parvoviruses, characterized by their tropism for blood cells, can manifest as asymptomatic infections. With their ability to persist in blood, assessing the prevalence of Parvovirus B19 (B19V) and Parvovirus 4 (PARV4) among healthy blood donors is essential for evaluating the potential transmission risks through blood transfusions, emphasizing the need for comprehensive screening protocols.
Methods: Four hundred blood donors participated in the study, with their blood specimens subjected to Real-Time PCR analysis for B19V and PARV4 nucleic acids after obtaining informed consent.
Polymer Micropatches as B-Cell Engagers.
ACS Appl Mater Interfaces
June 2024
Harvard John A. Paulson School of Engineering and Applied Sciences, Harvard University, Allston, Massachusetts 02134, United States.
B cells, despite their several unique functionalities, remain largely untapped for use as an adoptive cell therapy and are limited to use for antibody production. B cells can be easily sourced, they possess excellent lymphoid-homing capabilities, and they can act as antigen-presenting cells (APCs), offering an alternative to dendritic cells (DCs), which have shown limited efficacy in the clinical setting. Soluble factors such as IL-4 and anti-CD40 antibody can enhance the activation, survival, and antigen-presenting capabilities of B cells; however, it is difficult to attain sufficiently high concentrations of these biologics to stimulate B cells .
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!